PerkinElmer Inc (PKN MU) stock market data APIs
€78.3836
0(0%)
as of October 15, 2025
Try our APIs with
free plan!
PerkinElmer Inc Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for PKN.MU.
Prev. Close
78.3836
Open
78.3836
High
78.3836
Low
78.3836
52 wk Range
70.96-121.5754
Market Cap
20 984 M
Dividends (Yield)
0.003
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get PerkinElmer Inc data using free add-ons & libraries
Get PerkinElmer Inc Fundamental Data
PerkinElmer Inc Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
PerkinElmer Inc News
New
Research Tools & Consumables Stocks Q2 Teardown: Revvity (NYSE:RVTY) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at research tools & consumables stocks, st...
Revvity Showcases Progress with Purpose in 2025 Impact Report
Achievements span sustainability, social and governance initiatives WALTHAM, Mass., October 14, 2025--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today released its annual Impact Report, a comprehens...
Medpace and Revvity Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president...
RVTY Collaborates With Sanofi for Early Detection of Type 1 Diabetes
Revvity, Inc. RVTY announced a program aimed at transforming early detection of type 1 diabetes (T1D), a progressive autoimmune disorder affecting more than nine million people worldwide. The initiati...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
